Farms.com Home   News

Heard Health Expected to Determine Profitability in 2022

A partner with Polar Pork Farms says health status will be key in determining the economic strength of Saskatchewan's pork sector in the coming year. Amid feed costs that are more than double those of one year ago, lower global swine production resulting from losses due to African Swine Fever and herd reductions due to low returns, especially in China, have reduced global pork supplies.

Florian Possberg, a Partner with Polar Pork Farms, says we really didn't drop our production very much at all in Canada and should be in a good position through 2022 and into 2023.

Clip-Florian Possberg-Polar Pork Farms:

Locally, in Saskatchewan, we've benefitted from having just phenomenal health. Other parts of North American, including Manitoba and Ontario, have struggled with PED and PRRS and other challenges. We've been sparred that largely or almost exclusively in Saskatchewan so that's been a great benefit.

North America has benefitted because Russia and Europe and China and the whole of southeast Asia have challenged by African Swine Fever and even in parts with Foot and Mouth Disease. We've been sparred that in North America. We cross our fingers.

We do all we can, follow very strict biosecurity measures and monitoring so that we can keep those things out of our province. As long as we can keep those things out, we'll have an advantage but, because of the amount of freight going back and forth between Asia and North America, the chance of getting African Swine Fever is always there.

Source : Farmscape

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.